CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility to NGS Genetic DNA Test
Introduction
The CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility to NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with atypical hemolytic uremic syndrome (aHUS). This condition can lead to severe kidney damage and other serious health issues. Understanding your susceptibility to this disorder through genetic testing is crucial for proactive healthcare management.
What the Test Measures
This test specifically measures mutations in the CD46 gene, which plays a vital role in regulating the immune system and protecting cells from damage. By analyzing the genetic makeup of the patient, healthcare providers can assess the risk of developing aHUS.
Who Should Consider This Test
Individuals who may benefit from this test include:
- Patients with a family history of hemolytic uremic syndrome or related kidney disorders.
- Individuals experiencing symptoms such as unexplained anemia, kidney dysfunction, or neurological complications.
- Patients undergoing genetic counseling for hereditary conditions.
Benefits of Taking the Test
Undergoing the CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility Test offers several benefits:
- Early detection of genetic predispositions allows for timely interventions.
- Informed decision-making regarding family planning and management of potential health risks.
- Access to specialized care and treatment options based on genetic findings.
Understanding Your Results
Results from the CD46 Gene test will indicate whether any mutations were detected. A positive result may suggest a higher risk for developing aHUS, while a negative result may provide reassurance. It is essential to discuss results with a healthcare professional, who can offer guidance on the next steps, including potential monitoring or treatment options.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 40,000 KSh | 56,000 KSh |
Additional Information
The test requires a blood sample or extracted DNA, and results typically take 3 to 4 weeks. It is recommended that patients undergo a genetic counseling session to discuss their clinical history and draw a pedigree chart of affected family members prior to testing.
Book Your Test Today
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, offering convenient access to our testing services. To book the CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility to NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
